Organization | National Council of Scientific and Technical Research, Argentina

National Council of Scientific and Technical Research, Argentina Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Founded: Buenos Aires Argentina (1958)

Organization Overview

First Clinical Trial

1999

NCT02386358

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

National Council of Scientific and Technical Research, Argentina

Active Ingredients

Drugs in Phase 3 Trials (6)

arvac-cg (2 trials)

bacille calmette-guerin (1 trial)

benznidazole (Rochagan) (1 trial)

csf470 (1 trial)

Filgrastim (neupogen) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

Drugs in Phase 2 Trials (1)

platelet-rich plasma (1 trial)

Drugs in Phase 1 Trials (1)

Suicide plus immunogene therapy (1 trial)

Drugs in Other Trials (2)

ibuprofen (motrin) (1 trial)

psilocybin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Chagas Disease (Phase 3)

Melanoma (Phase 3)

Suicide (Phase 1)

Overview

Highest Phase: Phase 3
# of Trials: 8
# of Trial APIs: 10